Lipoglycopeptides [CS] - M000640741

Pharmacologic Class Information

Pharmacologic Code M000640741
Pharmacologic Name Lipoglycopeptides
Pharmacologic Uses
  • lipoglycopeptide antibacterial
Pharmacologic Concept Chemical Structure - [CS]
Pharmacologic Concept Description This concept refers to the chemical structure and classification containing chemicals or other drug ingredients, organized into a chemical structure classification hierarchy.

NDC Products with Lipoglycopeptides

The table contains 6 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptides [CS].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0480-3325Dalbavancin Non-Proprietary Name: DalbavancinInjection, Powder, For SolutionIntravenousTeva Pharmaceuticals, Inc.ACTIVE
57970-100Dalvance Non-Proprietary Name: DalbavancinInjection, Powder, For SolutionIntravenousAllergan, Inc.ACTIVE
65219-120Dalbavancin Hydrochloride Non-Proprietary Name: Dalbavancin HydrochlorideInjection, Powder, For SolutionIntravenousFresenius Kabi Usa, LlcACTIVE
70842-140Orbactiv Non-Proprietary Name: OritavancinInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE
70842-225Kimyrsa Non-Proprietary Name: Oritavancin DiphosphateInjection, Powder, Lyophilized, For SolutionIntravenousMelinta Therapeutics, LlcACTIVE
71288-034Dalbavancin Non-Proprietary Name: DalbavancinInjection, Powder, Lyophilized, For SolutionIntravenousMeitheal Pharmaceuticals IncACTIVE